Dai Z, Zhong Y, Cui Y, Ma Y, Zeng H, Chen Y
J Glob Health. 2024; 14:04129.
PMID: 38940273
PMC: 11212114.
DOI: 10.7189/jogh.14.04129.
Jankovic J, Jandric A, Djurdjevic N, Vukosavljevic D, Bojic Z, Zecevic A
Medicina (Kaunas). 2024; 60(5).
PMID: 38792978
PMC: 11122736.
DOI: 10.3390/medicina60050795.
Cakir Edis E, Cilli A, Kizilirmak D, Sakar Coskun A, Guler N, Cicek S
Balkan Med J. 2024; 41(3):206-212.
PMID: 38700365
PMC: 11077934.
DOI: 10.4274/balkanmedj.galenos.2024.2023-12-57.
Wei S, Lu R, Zhang Z, Wang F, Tan H, Wang X
BMC Pulm Med. 2022; 22(1):438.
PMID: 36424599
PMC: 9685983.
DOI: 10.1186/s12890-022-02254-x.
Lei J, Yang T, Liang C, Huang K, Wu S, Wang C
Front Med (Lausanne). 2022; 9:817048.
PMID: 35280888
PMC: 8914031.
DOI: 10.3389/fmed.2022.817048.
ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group.
Traversi L, Miravitlles M, Martinez-Garcia M, Shteinberg M, Bossios A, Dimakou K
ERJ Open Res. 2021; 7(4).
PMID: 34820447
PMC: 8607072.
DOI: 10.1183/23120541.00399-2021.
Prediction of exacerbation frequency of AECOPD based on next-generation sequencing and its relationship with imbalance of lung and gut microbiota: a protocol of a prospective cohort study.
Deng L, Yan J, Xu H, Huang C, Lv Y, Wu Q
BMJ Open. 2021; 11(9):e047202.
PMID: 34475159
PMC: 8413946.
DOI: 10.1136/bmjopen-2020-047202.
Chronic Obstructive Pulmonary Disease as a Phenotype of Bronchiectasis for Long-Term Clinical Presentation and Treatment.
Hsu C, Poon Y, Chen Y, Hsieh M, Lin H, Fang W
Medicina (Kaunas). 2021; 57(6).
PMID: 34198847
PMC: 8226788.
DOI: 10.3390/medicina57060579.
The effect of the presence and severity of bronchiectasis on the respiratory functions, exercise capacity, dyspnea perception, and quality of life in patients with chronic obstructive pulmonary disease.
Sahin H, Naz I, Susam S, Erbaycu A, Olcay S
Ann Thorac Med. 2020; 15(1):26-32.
PMID: 32002044
PMC: 6967141.
DOI: 10.4103/atm.ATM_198_19.
Prevalence and incidence of bronchiectasis in Italy.
Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F
BMC Pulm Med. 2020; 20(1):15.
PMID: 31948411
PMC: 6966816.
DOI: 10.1186/s12890-020-1050-0.
A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Fenker D, McDaniel C, Panmanee W, Panos R, Sorscher E, Sabusap C
Int J Respir Pulm Med. 2019; 5(2).
PMID: 30627668
PMC: 6322854.
DOI: 10.23937/2378-3516/1410098.
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement.
Gramegna A, Aliberti S, Confalonieri M, Corsico A, Richeldi L, Vancheri C
Multidiscip Respir Med. 2018; 13:39.
PMID: 30338069
PMC: 6174569.
DOI: 10.1186/s40248-018-0153-4.
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.
Flume P, Chalmers J, Olivier K
Lancet. 2018; 392(10150):880-890.
PMID: 30215383
PMC: 6173801.
DOI: 10.1016/S0140-6736(18)31767-7.
Precision medicine in COPD: where are we and where do we need to go?.
Sidhaye V, Nishida K, Martinez F
Eur Respir Rev. 2018; 27(149).
PMID: 30068688
PMC: 6156790.
DOI: 10.1183/16000617.0022-2018.
High prevalence of bronchiectasis in emphysema-predominant COPD patients.
Dou S, Zheng C, Cui L, Xie M, Wang W, Tian H
Int J Chron Obstruct Pulmon Dis. 2018; 13:2041-2047.
PMID: 29988718
PMC: 6029612.
DOI: 10.2147/COPD.S163243.
Exacerbations in COPD Patients with Bronchiectasis.
Minov J, Stoleski S, Mijakoski D, Vasilevska K, Atanasovska A
Med Sci (Basel). 2017; 5(2).
PMID: 29099023
PMC: 5635786.
DOI: 10.3390/medsci5020007.
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
Menendez R, Mendez R, Polverino E, Rosales-Mayor E, Amara-Elori I, Reyes S
Respir Res. 2017; 18(1):176.
PMID: 28964260
PMC: 5622554.
DOI: 10.1186/s12931-017-0659-x.
Patient participation in ERS guidelines and research projects: the EMBARC experience.
Chalmers J, Timothy A, Polverino E, Almagro M, Ruddy T, Powell P
Breathe (Sheff). 2017; 13(3):194-207.
PMID: 28894480
PMC: 5584721.
DOI: 10.1183/20734735.009517.
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.
Chalmers J, Crichton M, Goeminne P, Loebinger M, Haworth C, Almagro M
Breathe (Sheff). 2017; 13(3):180-192.
PMID: 28894479
PMC: 5584712.
DOI: 10.1183/20734735.005117.
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.
Al-Jahdali H, Alshimemeri A, Mobeireek A, Albanna A, Al Shirawi N, Wali S
Ann Thorac Med. 2017; 12(3):135-161.
PMID: 28808486
PMC: 5541962.
DOI: 10.4103/atm.ATM_171_17.
